Disclosure 0001649904-26-000013-2

SEC FORM 4

$182,170.10

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Sale of 1,556 shares at $117.0759 per share.

Reporting Person Garfield Alastair · Officer Title Chief Scientific Officer · Transaction Code S

Traded Aug 13, 2026 · Disclosed Aug 17, 2026

Source: SEC Form 4 · 0001649904-26-000013 · filed 2026-08-17 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "RHYTHM PHARMACEUTICALS, INC. (RYTM)." Disclosed 2026-08-17. https://desqlong.com/cards/0001649904-26-000013-2 (retrieved 2026-09-26).